Follow
Sprint Bioscience AB
Nasdaq First North GM (Sweden)
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Exercise
Price
8.25 SEK
Exercise period(s)
15 Feb - 14 Mar 2021
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
SPRINT
SE0006343745
Nasdaq First North GM
Sweden (SE)
Details of share in Sprint Bioscience AB with ticker SPRINT
Status
Active
Order book id
Amount of instruments
21 214 924
Par value
0.1000
Currency
SEK
Segment
First North Premier
First trading date
07 Nov 2014
Type
Price
Pre-money valuation
Time
Files
IPO
15.00 SEK
75.67M SEK
06 Oct - 24 Oct 2014
IPO in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Private placement
37.00 SEK
242.15M SEK
15 Mar 2016
Share issue in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Private placement
21.50 SEK
151.85M SEK
11 Sep 2017
Share issue in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
15.00 SEK
113.62M SEK
15 Feb - 06 Mar 2018
Share issue in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Exercise
17.17 SEK
173.41M SEK
28 Jan - 08 Feb 2019
Option exercise terms for SPRINT TO 2018/2019
Type
Price
Pre-money valuation
Time
Files
Private placement
14.00 SEK
03 Oct 2019
Share issue in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Exercise
14.50 SEK
178.97M SEK
14 Feb - 28 Feb 2020
Option exercise terms for SPRITN TO1
Type
Price
Pre-money valuation
Time
Files
Exercise
7.54 SEK
159.57M SEK
14 May - 28 May 2020
Option exercise terms for SPRINT TO2
Type
Price
Pre-money valuation
Time
Files
Rights issue
5.50 SEK
67.9M SEK
02 Jun - 16 Jun 2020
Share issue in Sprint Bioscience AB
Type
Ticker
ISIN
Market
OPTION
SPRITN TO 4
SE0014428199
Nasdaq First North GM
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRITN TO 4
Status
Active
Order book id
199488
Amount of instruments
4 956 067
Currency
SEK
Segment
First North Premier
Trading period
16 Jul 2020 - 10 Mar 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 8.25 during the subscription period from February 15, 2021 - March 14, 2021.
Update (08.07.2020): Sprint Bioscience AB announces the last day for trading with BTU and first day for trading in warrants TO 4.
Type
Price
Pre-money valuation
Time
Files
Exercise
8.25 SEK
175.02M SEK
15 Feb - 14 Mar 2021
Option exercise terms for SPRITN TO 4
Type
Ticker
ISIN
Market
SHARE
SPRINT
SE0006343745
Nasdaq First North GM
Sweden (SE)
Details of share in Sprint Bioscience AB with ticker SPRINT
Status
Active
Order book id
Amount of instruments
21 214 924
Par value
0.1000
Currency
SEK
Segment
First North Premier
First trading date
07 Nov 2014
Type
Price
Pre-money valuation
Time
Files
IPO
15.00 SEK
75.67M SEK
06 Oct - 24 Oct 2014
IPO in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Private placement
37.00 SEK
242.15M SEK
15 Mar 2016
Share issue in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Private placement
21.50 SEK
151.85M SEK
11 Sep 2017
Share issue in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
15.00 SEK
113.62M SEK
15 Feb - 06 Mar 2018
Share issue in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Private placement
14.00 SEK
03 Oct 2019
Share issue in Sprint Bioscience AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
5.50 SEK
67.9M SEK
02 Jun - 16 Jun 2020
Share issue in Sprint Bioscience AB
Type
Ticker
ISIN
Market
OPTION
SPRINT TO 2018/2019
SE0010833178
Nasdaq First North GM
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO 2018/2019
Status
Archived
Order book id
153717
Amount of instruments
Currency
SEK
Segment
First North Premier
Trading period
12 Apr 2018 - 06 Feb 2019
Terms
Three (3) warrants entitles the holder to subscribe for one (1) new share in the Company for the price which correspond to seventy (70) percent of the volume weighted average price for the Company's share on Nasdaq First North Premier during the period from and with January 14, 2019 to January 25, 2019, however, a minimum of SEK 15 and a maximum of SEK 29 per share. Subscription of shares with the support of warrants will take place during the period from January 28, 2019 - February 8, 2019.
Update (28.01.2019): The subscription period for warrants of series 2018/2019: 1 begins on January 28, 2019.
Type
Price
Pre-money valuation
Time
Files
Exercise
17.17 SEK
173.41M SEK
28 Jan - 08 Feb 2019
Option exercise terms for SPRINT TO 2018/2019
Type
Ticker
ISIN
Market
OPTION
SPRITN TO1
SE0013282050
Nasdaq First North GM
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRITN TO1
Status
Archived
Order book id
183922
Amount of instruments
1 073 640
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 Feb 2020
Terms
One (1) warrant of series TO1 entitles the holder to subscribe for one (1) new share in the Company for SEK 14.5 during the subscription period from February 14, 2020 - February 28, 2020.
Update (22.10.2019): The record date for obtaining free warrants in Sprint Bioscience AB is set for October 30, 2019.
Update (14.02.2020): The exercise period for warrants of series TO1 in Sprint Bioscience has begun.
Type
Price
Pre-money valuation
Time
Files
Exercise
14.50 SEK
178.97M SEK
14 Feb - 28 Feb 2020
Option exercise terms for SPRITN TO1
Type
Ticker
ISIN
Market
OPTION
SPRINT TO2
SE0013282068
Nasdaq First North GM
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRINT TO2
Status
Archived
Order book id
183923
Amount of instruments
1 073 640
Currency
SEK
Segment
First North Premier
Trading period
14 Feb 2020 - 26 May 2020
Terms
One (1) warrant of series TO2 entitles the holder to subscribe for one (1) new share in the Company for the price which corresponds to the volume-weighted share price on the Nasdaq First North Sweden during the period from April 27, 2020 - May 8, 2020 with a thirty (30) percent discount, but not more than SEK 16 per share. The subscription witht the support of warrants of series TO2 will take place from May 14, 2020 to May 28, 2020.
Update (22.10.2019): The record date for obtaining free warrants in Sprint Bioscience AB is set for October 30, 2019.
Update (14.05.2020): Exercise period for warrants of series TO2 2019 in Sprint Bioscience AB begins today.
Type
Price
Pre-money valuation
Time
Files
Exercise
7.54 SEK
159.57M SEK
14 May - 28 May 2020
Option exercise terms for SPRINT TO2
Type
Ticker
ISIN
Market
OPTION
SPRITN TO 4
SE0014428199
Nasdaq First North GM
Sweden (SE)
Details of option in Sprint Bioscience AB with ticker SPRITN TO 4
Status
Active
Order book id
199488
Amount of instruments
4 956 067
Currency
SEK
Segment
First North Premier
Trading period
16 Jul 2020 - 10 Mar 2021
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 8.25 during the subscription period from February 15, 2021 - March 14, 2021.
Update (08.07.2020): Sprint Bioscience AB announces the last day for trading with BTU and first day for trading in warrants TO 4.
Type
Price
Pre-money valuation
Time
Files
Exercise
8.25 SEK
175.02M SEK
15 Feb - 14 Mar 2021
Option exercise terms for SPRITN TO 4
People
Erik Kinnman
CEO
Rune Nordlander
Chairman of the board
Svein Mathisen
Board member
Erik Björk
Board member
Jan-Erik Nyström
Board member
Fredrik Lehmann
Board member
Company Details
Sector
HEALTH CARE

Address
Hälsovägen 7
Zip code
141 57
City/district
Huddinge
Country
Sweden (SE)
Registration number
556789-7557
LEI code
5493006ED74WIIQOKC56
First trade date
07 Nov 2014
Registration date
28 Sep 2009
Short name
Sprint

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More